Delivery Order SPE2DB20D1109-SPE2DB22FQ22P

Award Date 9/28/22
Potential Completion Date 9/29/22
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $16,066.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract provides for the delivery of Emtricitabine-Tenofovir 200-300 mg pharmaceutical products, which...
This federal contract award, valued at $1,844.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG medical products. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,054.80 delivery order contract is for the delivery of emtricitabine-tenofv 200-300mg medication, with a completion date of December 11, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,030.97. The contract was awarded by the Defense Logistics Agency (DLA) on July 6, 2022, with a completion date of July 7, 2022. The contract is for the delivery of emtricitabine-tenofovir 200-300mg medications, a critical pharmaceutical product used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,361.82 Firm Fixed Price Delivery Order covers the supply of Emtricitabine-Tenofv 100-150mg medication to support military and federal healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,211.12, is a Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 27, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.59, is a Delivery Order for the procurement of Emtricitabine-Tenofovir 200-300 mg medication. It is a Firm Fixed Price contract with a completion date of March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,371.76 Firm Fixed Price Delivery Order contract is for the provision of Emtricitabine-Tenofovir 200-300mg medication. The award, which has an ultimate completion date of August 3, 2023, falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.08 firm fixed-price delivery order contract is for the supply of 4563354076 emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of January 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.91, is a delivery order for the supply of emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of February 18, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FQ22P
    Delivery Order

This federal contract award, valued at $2,817.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559057040 - Emtricitabine-Tenofv 200-300mg, a pharmaceutical product, with a completion date of September 29, 2022.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:05 PM